Unlock stock picks and a broker-level newsfeed that powers Wall Street. Upgrade Now
0.0060
-0.0005
(-7.69%)
As of 5:00:02 PM GMT+1. Market Open.
Breakdown
9/30/2023
9/30/2022
9/30/2021
9/30/2020
Total Assets
16,127
11,344
15,379
14,931
Total Liabilities Net Minority Interest
10,072
8,756
8,686
1,772
Total Equity Gross Minority Interest
6,055
2,588
6,693
13,159
Total Capitalization
6,055
2,588
6,676
13,141
Common Stock Equity
6,055
2,588
6,676
13,141
Capital Lease Obligations
6,439
6,136
6,587
541
Net Tangible Assets
4,142
987
5,524
12,272
Working Capital
3,166
-146
4,386
11,595
Invested Capital
6,055
2,588
6,676
13,141
Tangible Book Value
4,142
987
5,524
12,272
Total Debt
6,439
6,136
6,587
541
Share Issued
202,303.4150
100,351.5740
92,559.7710
92,559.7710
Ordinary Shares Number
202,303.4150
100,351.5740
92,559.7710
92,559.7710
9/30/2020 - 1/19/2017
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
INTS Intensity Therapeutics, Inc.
2.2266
-4.85%
WXXWY WuXi Biologics (Cayman) Inc.
5.65
-0.88%
PTGX Protagonist Therapeutics, Inc.
38.61
+2.71%
NNVC NanoViricides, Inc.
1.2003
-9.07%
ROIV Roivant Sciences Ltd.
10.26
-4.46%
TNXP Tonix Pharmaceuticals Holding Corp.
7.44
-5.32%
ENVB Enveric Biosciences, Inc.
2.6450
-5.54%
NVAX Novavax, Inc.
7.94
-4.74%